News from the Department of Medicine

  • Lahey Interviewed by Vermont Public about Monkeypox
    (AUGUST 1, 2022) After the World Health Organization declared monkeypox a global health emergency and the first case of the virus was recently confirmed in Vermont, Tim Lahey, M.D., M.M.Sc., professor of medicine, spoke with Vermont Public about what we need to know about the virus, and who’s at highest risk.
  • Gosselin Talks Monkeypox in CreakyJoints
    (JULY 28, 2022) Rheumatologist Jeanne Gosselin, M.D., assistant professor of medicine, spoke with CreakyJoints about what monkeypox is and what people who are immunocompromised because of an autoimmune or inflammatory health condition or taking immunosuppressant medication need to know.
    Read full story at CreakyJoints.org
  • Knowridge Reports on Plante Study of ‘Stiff-Heart’ Patients and Beta-Blockers
    (JULY 27, 2022) A recent study by Timothy Plante, M.D., assistant professor of medicine, and colleagues found that so-called stiff-heart heart failure accounts for about half of all cases; in addition, most stiff-heart patients take beta-blocker medications despite unclear benefits from their regular use, according to Knowridge Science Report.
    Read full story at Knowridge Science Report
  • Lahey Tells WCAX Monkeypox is Likely Already Here
    (JULY 22, 2022) In an interview with WCAX-TV, infectious disease specialist Timothy Lahey, M.D., M.M.Sc., professor of medicine, said the number of confirmed cases of monkeypox has likely been undercounted because people with mild or no symptoms have not gone to a doctor for a diagnosis. Vermont health officials Friday said monkeypox is likely here even though there are still no confirmed cases in the state.
    Read full story at WCAX-TV
  • HealthDay Covers Sajisevi Study of Thyroid Cancers in Asymptomatic Patients
    (JULY 19, 2022) More than half of thyroid cancers are identified among patients with no symptoms, according to a study by Mirabelle Sajisevi, M.D., associate professor of surgery, and colleagues, HealthDay News reported.
    Read full story at HealthDay News
  • Teaching Academy Announces 2022 Frymoyer Scholars Projects & Investigators
    Three Larner College of Medicine faculty-led, interprofessional group projects have been selected to receive 2022 Frymoyer Scholars funding. The three projects focus on newborn resuscitation, building an interdisciplinary gender affirming care model, and fostering excellent clinical teachers, respectively.
  • Holcombe Touts Benefits of Early Lung Cancer Screening in Burlington Free Press Article
    (JULY 15, 2022) UVM Cancer Center director Randall Holcombe, M.D., M.B.A., told the Burlington Free Press that the center, together with the Dartmouth Cancer Center and Vermonters Taking Action Against Cancer, has launched a campaign to increase screening for lung cancer — the leading cause of cancer death in Vermont and the country.
    Read full story at Burlington Free Press
  • Lahey Warns WCAX of ‘Peaks and Valleys’ in COVID-19 Pandemic
    (JULY 13, 2022) As Vermonters contemplate the future of COVID-19, infectious disease expert Timothy Lahey, M.D., M.M.Sc., professor of medicine, said in an interview with WCAX-TV that there are going to be peaks and valleys during the pandemic.
    Read full story at WCAX-TV
  • Dr. Polly Parsons: Looking Back and Moving Forward
    On July 11, E.L. Amidon Chair and Professor of Medicine Polly Parsons, M.D., began the transition to her new role as President and CEO of the Alliance for Academic Internal Medicine (AAIM). We sat down with Dr. Parsons to reflect on her 16 years at the helm of the department, review her accomplishments and consider the department’s growth, struggles and triumphs.
  • VCCBH Symposium Highlights Early Career Investigators, Innovative Multidisciplinary Research
    More than 100 in-person and dozens of virtual participants attended the second annual Vermont Center for Cardiovascular and Brain Health (VCCBH) Symposium, held at the University of Vermont’s Davis Center June 2 to 3, 2022. The VCCBH, one of three National Institutes of Health Center of Biomedical Research Excellence-funded programs at UVM, is co-directed by Mary Cushman, M.D., M.Sc., professor and vice chair for emerging researchers in the Department of Medicine, and Mark Nelson, Ph.D., University Distinguished Professor and chair of the Department of Pharmacology.
  • Medical Class of 2022 Honors Night Recognizes Faculty, Students & Staff
    On May 13, the Larner College of Medicine at the University of Vermont held Honors Night for graduating medical students in the Class of 2022. Accolades presented included the Alpha Omega Alpha Honor Medical Society faculty, housestaff, and community physician awards; the Arnold P. Gold Foundation's Leonard Tow Humanism in Medicine faculty and student awards; Area Health Education Center Scholars; department awards to students; and awards from the Class of 2022.
  • Parsons Named President and CEO of Alliance for Academic Internal Medicine
    Polly Parsons, M.D., E.L. Amidon Chair and Professor of Medicine, has been named the next president and CEO of the Alliance for Academic Internal Medicine.
  • Lahey Comments on New Wave of COVID Infections on WCAX-TV
    (MAY 2, 2022) Professor of Medicine Tim Lahey, M.D., M.M.Sc., spoke with WCAX-TV Channel 3’s Christina Guessferd about another wave of COVID infections and hospitalizations in Vermont.
  • Dixon Named 2022-23 University Scholar
    Anne Dixon, M.A., BM BCh, professor of medicine, has been named one of four 2022-2023 University Scholars.
  • Inaugural Research Week Features Larner Faculty and Trainee Investigation & Innovation
    In celebration of its standing as a top 100 public research university, the University of Vermont held its first “Research Week” April 18 to 22 to showcase the work of faculty, student and trainee investigators. A number of Larner College of Medicine faculty and trainees received recognition and delivered presentations during the week's events.
  • Integrating Mental Health into Pediatric Primary Care
    UVM Pediatric Primary Care is removing barriers to mental health care with an evidence-based Primary Care Mental Health Integration program, piloted with support from the UVM Health Network.
  • Kirkpatrick Presents University Scholar Lecture on Combatting Global Infectious Diseases
    University of Vermont Chair of Microbiology and Molecular Genetics Beth Kirkpatrick, M.D., will present her 2021-22 University Scholar lecture on "Combatting Global Infectious Diseases: Vaccines and Human Models," on Monday, April 4, 2022.
  • New Study Highlights Colorectal Cancer Treatments that Improve Patients' Quality of Life
    In recent years, total neoadjuvant treatment—a potent new therapy for advanced colorectal cancer—has emerged as the standard of care. But the treatment can be harsh, impacting quality of life for many patients. A new study published in Clinical Colorectal Cancer by a team of researchers affiliated with the University of Vermont Cancer Center highlights a variety of new colorectal cancer treatments that take into account both a patient’s likely health outcome and quality of life factors.
  • Heart Month: Bouncing Back after Atypical Heart Attack
    A heart attack struck 44-year-old Sara Rutledge during her daily run. Thanks to the competence and care of a team of clinicians at Central Vermont Medical Center and UVM Medical Center, she received a diagnosis for spontaneous coronary artery dissection - or SCAD - has had a successful recovery, and is back to doing her favorite activities.
  • Menson & Kaminsky Featured in VTDigger Story on Long-COVID Research
    (FEBRUARY 22, 2022) Pulmonologists David Kaminsky, M.D., professor of medicine, and Katherine Menson, D.O., assistant professor of medicine, spoke with Mike Dougherty of VTDigger for a story titled “Vermonters with ‘Long Covid’ Still Face Barriers to Care.”